Medical and Pharmaceutical Optellum breaks new ground with TGA approval for AI-powered lung nodule solution 'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it Rowan DunneMarch 5, 2026
Medical and Pharmaceutical Minnesota’s Vocxi Health and Forj Medical report success with lung cancer breath test It uses nanosensors and AI algorithms to detect volatile organic compounds linked to the disease Rowan DunneMarch 3, 2026
Medical and Pharmaceutical Kairos Pharma acquires lung cancer drug assets from Celyn Therapeutics Shares surged by 16% after the deal was announced Rowan DunneMarch 2, 2026
Medical and Pharmaceutical Icahn researchers target lysosomes to reverse stem cell aging The research focused on hematopoietic stem cells, often called HSCs Joseph MortonFebruary 26, 2026
Medical and Pharmaceutical Allarity Therapeutics doses first patients in VA-funded small cell lung cancer trial The drug being examined, stenoparib, is also showing promise in ovarian cancer treatment Rowan DunneFebruary 24, 2026
Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan DunneFebruary 23, 2026
Medical and Pharmaceutical GRAIL plunges hard after ‘Galleri’ multi-cancer test fails to meet primary endpoint The slide comes in tandem with financial results that beat expectations Rowan DunneFebruary 20, 2026
Medical and Pharmaceutical Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation The FDA grants Breakthrough Device status to a limited group of technologies Joseph MortonFebruary 19, 2026
Medical and Pharmaceutical UBC scientists discover key to mass-producing helper T-cells for cancer treatment Cell therapies have gained ground in recent years as doctors turn patients’ immune systems into “living drugs.” Joseph MortonFebruary 18, 2026
Medical and Pharmaceutical Chinese researchers reveal optical sensor for early lung cancer detection The group combined DNA nanostructures, quantum dots and CRISPR gene-editing tools with a light-based technique called second harmonic generation Joseph MortonFebruary 17, 2026